SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-015695
Filing Date
2021-03-16
Accepted
2021-03-16 16:11:45
Documents
2
Period of Report
2021-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea137737-8k_enzobiochem.htm 8-K 16063
2 PRESS RELEASE OF ENZO BIOCHEM, INC., DATED MARCH 15, 2021 ea137737ex99-1_enzobiochem.htm EX-99.1 92871
  Complete submission text file 0001213900-21-015695.txt   110212
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 21745818
SIC: 8071 Services-Medical Laboratories